Safety and Efficacy Study of High Dose Melphalan to Treat Multiple Myeloma
Status:
Unknown status
Trial end date:
2014-06-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to evaluate the safety and effectiveness of melphalan for
injection for autologous stem cell transplant in multiple myeloma